Argonaute-2 promotes miR-18a entry in human brain endothelial cells.

J Am Heart Assoc · 2014 · PMC4309089 · PMID 24837588

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Imaging data also showed that mice treated with miR‐18a alone and in combination with Ago‐2 showed a trend towards reduced tumor growth compared to vehicle treatment, although these differences were not significant (Figures 6 D and 6 E).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.